Altimmune, Inc.
ALT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326190
In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.
Q3 2023 vs. Q2 2023
How the institutions holding Altimmune, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 120 | 1 | 113 | −6 |
| Shares | 35.3M | 75.0K | 30.3M | −4.88M (−13.9%) |
| Value | $124.5M | $264.8K | $79.2M | −$45.0M (−36.3%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Altimmune, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Prudential Financial Inc | 333,255 | $866.5K | 0.00% |
| XTX Topco Ltd | 204,998 | $533.0K | 0.09% |
| Gagnon Securities LLC | 111,522 | $290.0K | 0.07% |
| LMR Partners LLP | 44,508 | $115.7K | 0.00% |
| Deutsche Bank AG | 30,428 | $79.1K | 0.00% |
| Timelo Investment Management Inc. | 30,000 | $78.0K | 0.22% |
| Miracle Mile Advisors, LLC | 17,000 | $44.2K | 0.00% |
| Quantbot Technologies LP | 15,300 | $39.8K | 0.00% |
| Brave Asset Management Inc | 15,000 | $39.0K | 0.01% |
| Keudell/Morrison Wealth Management | 14,000 | $36.4K | 0.01% |
| Vahanian & Associates Financial Planning Inc. | 13,760 | $35.8K | 0.11% |
| Prelude Capital Management, LLC | 12,600 | $32.8K | 0.00% |
| Russell Investments Group, Ltd. | 344 | $894 | 0.00% |
| Nisa Investment Advisors, LLC | 113 | $294 | 0.00% |
| Team Financial Group, LLC | 2 | $5 | 0.00% |
| Cornerstone Planning Group LLC | 1 | $3 | 0.00% |
Sold out (22)
Institutions that held Altimmune, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Sphera Funds Management Ltd. | 500,000 | $1.76M |
| Walleye Capital LLC | 419,783 | $1.48M |
| Rock Springs Capital Management LP | 223,255 | $788.1K |
| Knoll Capital Management, LLC | 173,864 | $613.7K |
| Squarepoint Ops LLC | 139,911 | $493.9K |
| Schonfeld Strategic Advisors LLC | 68,100 | $240.4K |
| Dana Investment Advisors, Inc. | 58,740 | $207.4K |
| Envestnet Asset Management Inc | 30,986 | $109.4K |
| Bayesian Capital Management, LP | 30,175 | $106.5K |
| UBS Asset Management Americas Inc | 19,200 | $81.0K |
| Tudor Investment Corp Et Al | 22,501 | $79.4K |
| Jump Financial, LLC | 21,249 | $75.0K |
| Delphia (USA) Inc. | 21,205 | $74.9K |
| Allspring Global Investments Holdings, LLC | 19,842 | $70.0K |
| State of Wisconsin Investment Board | 18,000 | $63.5K |
| State Board of Administration of Florida Retirement System | 14,030 | $49.5K |
| Point72 Middle East FZE | 12,097 | $42.7K |
| Pitcairn Co | 11,960 | $42.2K |
| Aigen Investment Management, LP | 11,712 | $41.3K |
| Wolverine Trading, LLC | 10,553 | $36.9K |
| Umb Bank N A | 2,368 | $8.36K |
| Sofos Investments, Inc. | 4 | $9 |
Not filed for Q3 2023 yet (1)
Institutions that held Altimmune, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 75,000 | $264.8K |